Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients

NCT04891172 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: Anti COVID 19 Intravenous Immunoglobulin (C-IVIG)

Sponsor

Dow University of Health Sciences

Collaborators

[object Object]